A ropy exopolysaccharide producing strain <i>Bifidobacterium longum</i> subsp. <i>longum</i> YS108R alleviates DSS-induced colitis by maintenance of the mucosal barrier and gut microbiota modulation
A ropy exopolysaccharide producing strain <i>Bifidobacterium longum</i> subsp. <i>longum</i> YS108R alleviates DSS-induced colitis by maintenance of the mucosal barrier and gut microbiota modulation is a paper indexed in ScholarIQ from OpenAlex.
How many citations does A ropy exopolysaccharide producing strain <i>Bifidobacterium longum</i> subsp. <i>longum</i> YS108R alleviates DSS-induced colitis by maintenance of the mucosal barrier and gut microbiota modulation have?
A ropy exopolysaccharide producing strain <i>Bifidobacterium longum</i> subsp. <i>longum</i> YS108R alleviates DSS-induced colitis by maintenance of the mucosal barrier and gut microbiota modulation has 158 citations in the OpenAlex counts ScholarIQ stores.
When was A ropy exopolysaccharide producing strain <i>Bifidobacterium longum</i> subsp. <i>longum</i> YS108R alleviates DSS-induced colitis by maintenance of the mucosal barrier and gut microbiota modulation published?
A ropy exopolysaccharide producing strain <i>Bifidobacterium longum</i> subsp. <i>longum</i> YS108R alleviates DSS-induced colitis by maintenance of the mucosal barrier and gut microbiota modulation has 2019 year in the ScholarIQ index.
What is the open-access status of A ropy exopolysaccharide producing strain <i>Bifidobacterium longum</i> subsp. <i>longum</i> YS108R alleviates DSS-induced colitis by maintenance of the mucosal barrier and gut microbiota modulation?
A ropy exopolysaccharide producing strain <i>Bifidobacterium longum</i> subsp. <i>longum</i> YS108R alleviates DSS-induced colitis by maintenance of the mucosal barrier and gut microbiota modulation has closed oa status in the ScholarIQ index.
What is the DOI of A ropy exopolysaccharide producing strain <i>Bifidobacterium longum</i> subsp. <i>longum</i> YS108R alleviates DSS-induced colitis by maintenance of the mucosal barrier and gut microbiota modulation?
The DOI for A ropy exopolysaccharide producing strain <i>Bifidobacterium longum</i> subsp. <i>longum</i> YS108R alleviates DSS-induced colitis by maintenance of the mucosal barrier and gut microbiota modulation is on the source record.
What is the PMID of A ropy exopolysaccharide producing strain <i>Bifidobacterium longum</i> subsp. <i>longum</i> YS108R alleviates DSS-induced colitis by maintenance of the mucosal barrier and gut microbiota modulation?
The PMID for A ropy exopolysaccharide producing strain <i>Bifidobacterium longum</i> subsp. <i>longum</i> YS108R alleviates DSS-induced colitis by maintenance of the mucosal barrier and gut microbiota modulation is on the source record.
What is the OpenAlex record for A ropy exopolysaccharide producing strain <i>Bifidobacterium longum</i> subsp. <i>longum</i> YS108R alleviates DSS-induced colitis by maintenance of the mucosal barrier and gut microbiota modulation?
The OpenAlex for A ropy exopolysaccharide producing strain <i>Bifidobacterium longum</i> subsp. <i>longum</i> YS108R alleviates DSS-induced colitis by maintenance of the mucosal barrier and gut microbiota modulation is on the source record.